EVERLAST-A: A Phase 2a Study Design of ORKA-001, a Novel Half-Life Extended IL-23p19 Monoclonal Antibody for Plaque Psoriasis. J of Skin [Internet]. 2025 Nov. 10 [cited 2026 May 1];9(6):s633. Available from: https://skin.dermsquared.com/skin/article/view/3768